Non-alcoholic fatty liver disease is a condition that is characterized by the presence of> 5%
fat in the liver and affects more than one billion people worldwide. If adequate and early …

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …

Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …

In the world, nonalcoholic fatty liver disease (NAFLD) accounts for majority of diffuse hepatic
diseases. Notably, substantial liver fat accumulation can trigger and accelerate hepatic …

An abundance of fat stored within the liver, or steatosis, is the beginning of a broad
hepatological spectrum, usually referred to as fatty liver disease (FLD). For studies on FLD …

Hepatic steatosis is characterized by abnormal and excessive accumulation of lipids within
hepatocytes. It is an important feature of diffuse liver disease, and the histological hallmark …

Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United
States. While the American Association for the Study of Liver Diseases guidelines define …

Hepatic steatosis is the most prevalent liver disorder in the developed world. It is closely
associated with features of metabolic syndrome, especially insulin resistance and obesity …

Hepatic steatosis is a frequently encountered imaging finding that may indicate chronic liver
disease, the most common of which is non-alcoholic fatty liver disease. Non-alcoholic fatty …